Release Date: 10/02/21 08:53 Summary: CSR Limited Final share buy-back notice - Appendix 3F Price Sensitive: No Download Document 253.37KB Download
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution